natgillin/translations-raw huggingface dataset:
Later in 2012 the marketing authorisation holder, Vet-Agro Trading Sp. z o.o., submitted applications for mutual recognition of the marketing authorisation granted by the Czech Republic for the aforementioned five presentations of Fiprex. 
Kasneje leta 2012 je imetnik dovoljenja za promet z zdravilom, družba Vet-Agro Trading Sp. z o.o., predložil vloge za postopek z medsebojnim priznavanjem za dovoljenja za promet z zdravili, odobrena v Češki republiki, za zgoraj omenjenih pet različic zdravila Fiprex.
for up to 28 days after administration, for the control of Flea Allergy Dermatitis, as well as for treatment and prevention of tick (Ixodes spp., Rhipicephalus sanguineus and Dermacentor reticulatus) infestations between 7 and 21 days after administration. 
do 28 dni po nanosu, za nadzor alergijskega dermatitisa, ki ga povzročajo bolhe, ter tudi za zdravljenje in preprečevanje infestacij s klopi (Ixodes spp., Rhipicephalus sanguineus in Dermacentor reticulatus) od 7 do 21 dni po nanosu.
On day 90 of the mutual recognition procedure these issues remained unsolved and therefore a referral procedure under Article 33(1) of Directive 2001/82/EC to the veterinary coordination group for the mutual recognition and decentralised procedures (CMDv) was started on 18 February 2013. 
Ker ti pomisleki na 90. dan postopka z medsebojnim priznavanjem še vedno niso bili rešeni, je bila zadeva 18. februarja 2013 v skladu s členom 33(1) Direktive 2001/82/ES napotena na Usklajevalno skupino za postopek z medsebojnim priznavanjem in decentralizirani postopek - zdravila za uporabo v veterinarski medicini (CMD(v)).
On 9 April 2014, the CVMP adopted by majority a final opinion confirming the recommendation included in its opinion of 11 December 2013, that the granting of the marketing authorisations should be refused and the existing marketing authorisations should be suspended for Fiprex CAT 52.5 mg spot-on solution for cats, Fiprex S 75 mg spot-on solution for dogs, Fiprex M 150 mg spot-on solution for dogs, Fiprex L 300 mg spot-on solution for dogs and Fiprex XL 412.5 mg spot-on solution for dogs. 
Dne 9. aprila 2014 je Odbor CVMP z večino sprejel končno mnenje, v katerem je potrdil priporočilo, vključeno v mnenje odbora z dne 11. decembra 2013, za zavrnitev vlog za izdajo dovoljenj za promet z zdravilom in začasen umik obstoječih dovoljenj za promet z zdravilom za zdravila Fiprex CAT 52,2 mg kožni nanos, raztopina za mačke, Fiprex S 75 mg kožni nanos, raztopina za pse, Fiprex M 150 mg kožni nanos, raztopina za pse, Fiprex L 300 mg kožni nanos, raztopina za pse in Fiprex XL 412,5 mg kožni nanos, raztopina za pse.
infestations for up to 28 days, as well as for the control of Flea Allergy Dermatitis. 
do 28 dni ter tudi za nadzor alergijskega dermatitisa, ki ga povzročajo bolhe.
Fiprex is a veterinary medicinal product presented as a spot-on formulation containing fipronil as an active substance (pharmacotherapeutic group: ectoparasiticides for topical use). 
Zdravilo Fiprex je zdravilo za uporabo v veterinarski medicini v obliki formulacije za kožni nanos, ki vsebuje zdravilno učinkovino fipronil (farmakoterapevtska skupina: ektoparazitiki za lokalno uporabo).
52.5 mg spot-on solution for cats; Fiprex S 75 mg spoton solution for dogs, Fiprex M 150 mg spot-on solution for dogs, Fiprex L 300 mg spot-on solution for dogs, Fiprex XL 412.5 mg spot-on solution for dogs 
75 mg kožni nanos, raztopina za pse, Fiprex M 150 mg kožni nanos, raztopina za pse, Fiprex L 300 mg kožni nanos, raztopina za pse, in Fiprex XL 412,5 mg kožni nanos, raztopina za pse
The detailed grounds for the re-examination request were submitted by Vet-Agro Trading Sp. z o.o. 
Podrobne razloge za zahtevo za ponovni pregled je družba Vet-Agro Trading Sp. z o.o predložila 10. februarja 2014.
The legal basis of the applications was also Article 13a of Directive 2001/82/EC. 
primeru člen 13a Direktive 2001/82/ES.
Fiprex for cats is indicated for the treatment and prevention of flea (Ctenocephalides spp.) 
Pri mačkah je zdravilo Fiprex indicirano za zdravljenje in preprečevanje infestacij z bolhami (Ctenocephalides spp.)
Fiprex for dogs is indicated for the treatment and prevention of flea infestations (Ctenocephalides spp.) 
Pri psih je zdravilo Fiprex indicirano za zdravljenje in preprečevanje infestacij z bolhami (Ctenocephalides spp.)
Opinion following an Article 33(4)1 referral for Fiprex CAT 
Mnenje po napotitvi iz člena 33(4)
Take the capsules on an empty stomach; for example, at least one hour before you plan to eat breakfast. 
Kapsule vzemite na prazen želodec, na primer eno uro, preden nameravate zajtrkovati.
You may also need other treatments. 
Morda boste potrebovali tudi druge načine zdravljenja.
The reduction in blood cell counts is usually short-lived. 
Zmanjšanje števila krvnih celic je ponavadi kratkotrajno.
Capsules should not be opened. 
Kapsule se ne smejo odpreti.
You should make sure you fully understand and remember the following: - the number of capsules you need to take every dosing day. 
Naslednje podatek morate dobro razumeti in si jih zapomniti: - število kapsul, ki jih morate vzeti vsak dan odmerjanja.
The marking on the capsule is different for each strength (see table below). 
Oznaka na kapsuli je pri vsaki jakosti drugačna (glejte spodnjo tabelo).
In this case, do not drive or use any tools or machines or cycle until you see how this medicine affects you (see section 4). 
V tem primeru ne vozite in ne upravljajte z orodji ali s stroji ali se voziti s kolesom, dokler ne ugotovite, kako to zdravilo vpliva na vas (glejte poglavje 4).
These blood cells are important for fighting infection and for proper blood clotting. 
Te krvne celice so pomembne za premagovanje okužb in pravilno strjevanje krvi.
Depending on the prescribed dose, you may have to take more than one capsule at the same time. 
Odvisno od predpisanega odmerka boste morda morali vzeti več kapsul hkrati.
Once the radiotherapy is completed, you will have no treatment for 4 weeks. 
Ko se obsevanje zaključi, štiri tedne ne boste prejemali nobenega zdravljenja.
In this case, your doctor will also prescribe medicine to help you prevent this type of pneumonia (PCP). 
V tem primeru vam bo zdravnik predpisal tudi zdravilo za preprečevanje tovrstne pljučnice (PCP).
The following side effects may occur, and may require medical attention. 
Lahko se pojavijo naslednji neželeni učinki, zaradi katerih bo morda potrebna zdravniška pomoč.
Hard capsule (capsule). 
Trde kapsule (kapsula).
Making a mistake in how you take this medicine may have serious health consequences. 
Če se pri jemanju zdravila zmotite, s tem tvegate resne zdravstvene posledice.
Date of first authorization: 13 July 2011 Date of latest renewal: 21 April 2016 
Datum zadnjega podaljšanja: 21. aprila 2016
Your doctor will monitor your blood regularly for any changes, and will decide if any specific treatment is needed. 
Zdravnik bo redno preverjal vašo kri za morebitne spremembe in se bo odločil, ali potrebujete kakršnokoli posebno zdravljenje .
Your doctor may decide to reduce the dose, interrupt, stop or change your treatment. 
Zdravnik se bo morda odločil, da boste jemali manjši odmerek, prekinili, končali ali spremenili zdravljenje.
Hepatitis B virus 
Virusom hepatitisa B
If a full day has gone by, check with your doctor. 
Če je minil že cel dan, se posvetujte z zdravnikom.
† Including cases with fatal outcome * Frequencies estimated based on relevant clinical trials. 
† vključno s primeri s smrtnim izidom * Ocena pogostnosti temelji na ustreznih kliničnih preskušanjih.
In some cases, it may be prolonged and may lead to a very severe form of anaemia (aplastic anaemia). 
V nekaterih primerih pa traja dlje in lahko vodi v zelo hudo obliko anemije (anaplastično anemijo).
You will take this dose every day for 42 to 49 days in combination with radiotherapy. 
Ta odmerek boste jemali vsak dan 42 do 49 dni, v kombinaciji z obsevanjem.
Side effects from clinical studies 
Neželeni učinki iz kliničnih študij
The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal. 
• Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve glede predložitve PSUR za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
This daily dose depends on whether or not you have received chemotherapy before. 
Ta dnevni odmerek je odvisen od tega, ali ste se že kdaj zdravili s kemoterapijo.
Temozolomide SUN may make you feel tired or sleepy. 
Zaradi zdravila Temozolomid SUN se lahko počutite utrujeni ali zaspani.
Then, you will start the monotherapy phase. 
Nato boste začeli s fazo monoterapije.
As it cannot be excluded that the change in Cmax is clinically significant, Temozolomide SUN should be administered without food. 
Ker ni mogoče izključiti možnosti, da bi bila sprememba Cmax lahko klinično pomembna, naj bolniki jemljejo zdravilo Temozolomid SUN brez hrane.
Temozolomide SUN treatment can cause a reduction in certain kinds of blood cells. 
Zdravljenje z zdravilom Temozolomid SUN lahko povzroči zmanjšanje števila določenih vrst krvnih celic.
After day 28, the next cycle will begin. 
Po 28 dneh se bo začel nov cikel.
This is because you must not be treated with Temozolomide SUN during pregnancy unless clearly indicated by your doctor. 
To morate storiti zato, ker se med nosečnostjo ne smete zdraviti z zdravilom Temozolomid SUN, razen če vam je to izrecno predpisal vaš zdravnik.
A treatment cycle with Temozolomide SUN lasts 28 days. 
Cikel zdravljenja z zdravilom Temozolomid SUN traja 28 dni.
There may be up to 6 treatment periods (cycles). 
Zdravljenje bo potekalo v največ šestih obdobjih (ciklih).
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se z njim posvetujte, preden začnete jemati to zdravilo.
Depending on your blood test results, your doctor may adjust your dose for the next cycle. 
Glede na rezultate krvnih preiskav vam bo zdravnik morda prilagodil odmerek za naslednji cikel zdravljenja.
You may be given other medicines (anti-emetics) to take before and/or after taking Temozolomide SUN to prevent or control nausea and vomiting. 
Morda boste dobili druga zdravila (antiemetike), ki jih boste vzeli zdravilom Temozolomid SUN in/ali po njem, za preprečevanje ali nadzor slabosti in bruhanja.
Skin exfoliation, 
luščenje kože,
- if you have low counts of red blood cells (anaemia), white blood cells and platelets, or blood clotting problems before starting the treatment, or if you develop them during treatment. 
- če imate pred začetkom zdravljenja majhno število rdečih krvnih celic (anemija), belih krvnih celic in krvnih ploščica ali težave s strjevanjem krvi, ali če se to razvije med zdravljenjem.
This may cause you to have increased bruising or bleeding, anaemia (a shortage of red blood cells), fever, and reduced resistance to infections. 
Zato boste morda imeli pogostejše podplutbe ali krvavitve, anemijo (pomanjkanje rdečih krvnih celic), vročino in zmanjšano odpornost proti okužbam.
In very rare cases, patients taking Temozolomide SUN and medicines like it may have a small risk of developing secondary cancers, including leukaemia. 
Pri zelo redkih bolnikih, ki jemljejo zdravilo Temozolomid SUN in podobna zdravila, obstaja majhno tveganje za razvoj sekundarnega raka, vključno z levkemijo.
Temozolomide SUN is used in these tumours if they return or get worse after standard treatment. 
Zdravilo Temozolomid SUN se uporablja za zdravljenje teh tumorjev, če se po standardnem zdravljenju ponovijo ali poslabšajo.
Tell your doctor if you notice any of these symptoms. 
Če opazite katerega od teh simptomov,
Frequency not known: 
Pogostnost neznani:
These reactions were usually Grade 1 or 2 (0-5 episodes of vomiting in 24 hours) and were either self-limiting or readily controlled with standard anti-emetic therapy. 
Oba učinka sta bila ponavadi 1. ali 2. stopnje (od 0 do 5 epizod bruhanja v 24 urah) in sta prenehala sama ali pa ju je bilo mogoče hitro obvladati s standardnim antiemetičnim zdravljenjem.
TMZ + concomitant RT n=288* 
TMZ + sočasna radioterapija n=288*
Dose levels include 100 mg/m2, 150 mg/m2, and 200 mg/m2. 
Stopnje odmerka so 100 mg/m2, 150 mg/m2 in 200 mg/m2.
Very rare cases of severe rash with skin swelling, including on the palms of the hands and soles of the feet, or painful reddening of the skin and/or blisters on the body or in the mouth have been observed. 
Opazili so zelo redke primere hudega izpuščaja z otekanjem kože, vključno z dlanmi in podplati, ali boleče pordelosti kože in/ali mehurjev na telesu ali v ustih.
If you vomit frequently before or during treatment, ask your doctor about the best time to take Temozolomide SUN until the vomiting is under control. 
Če pred zdravljenjem ali med njim pogosto bruhate, vprašajte zdravnika, kdaj je najbolje jemati zdravilo Temozolomid SUN, dokler se bruhanje ne umiri.
Pharmacotherapeutic group: Antineoplastic agents, other alkylating agents, ATC code: L01A X03. 
Farmakoterapevtska skupina: Antineoplastična zdravila - drugi alkilirajoči citostatiki, oznaka ATC: L01A X03
Review the dose with your doctor each time you start a new cycle, since it may be different from the last cycle. 
Vsakič ko začnete nov ciklus, z zdravnikom ponovno preverite odmerek, saj se lahko razkikuje od prejšnjega.
The first dose will be 150 mg/m2. 
Prvi odmerek bo 150 mg/m2.
Take your prescribed dose of Temozolomide SUN once a day, preferably at the same time each day. 
Predpisani odmerek zdravila Temozolomid SUN vzemite enkrat dnevno, najbolje vsak dan ob istem času.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements. 
Neuporabljena zdravila ali odpadni material morajo biti odstranjeni v skladu z lokalnimi zahtevami.
In some cases, your Temozolomide SUN dose will be reduced or treatment stopped. 
V nekaterih primerih je treba odmerek zdravila Temozolomid SUN zmanjšati ali zdravljenje končati.
Summary of events reported with temozolomide in the post-marketing setting* 
Povzetek dogodkov, o katerih so poročali pri uporabi temozolomida v obdobju trženja
drug reaction with eosinophilia and systemic symptoms (DRESS) 
reakcija na zdravilo z eozinofilijo in sistemskimi simptomi (DRESS)
- as you should be observed closely for the development of a serious form of chest infection called Pneumocystis jirovecii pneumonia (PCP). 
- ker vas mora zdravnik pozorno opazovati zaradi možnosti pojava resne oblike okužbe dihal, imenovane pljučnica zaradi okužbe s Pneumocystis jirovecii (PCP).
Before each new treatment cycle, your blood will be tested to see if the Temozolomide SUN dose needs to be adjusted. 
Pred vsakim ciklom zdravljenja boste opravili preiskavo krvi, da bi ugotovili, ali je treba odmerek zdravila Temozolomid SUN prilagoditi.
Data on clinical efficacy in patients with glioblastoma multiforme (Karnofsky performance status [KPS] ≥ 70), progressive or recurrent after surgery and RT, were based on two clinical trials with oral TMZ. 
Podatki o klinični učinkovitosti zdravila pri bolnikih z multiformnim glioblastomom (indeks kliničnega stanja po Karnofskyju [KPS - »Karnofsky performance status«] ≥ 70), ki napreduje ali se je ponovil po kirurškem posegu in RT, temeljijo na dveh kliničnih preskušanjih s peroralno uporabo TMZ.
Table 5 includes adverse reactions reported during clinical trials for recurrent or progressive malignant glioma and following the marketing of Temozolomide SUN. 
V preglednici 5 so navedeni neželeni učinki, ki so jih prijavili v kliničnih preskušanjih pri ponavljajočem ali napredujočem malignem gliomu in po trženju zdravila Temozolomid SUN.
You may have to take different strengths to make up the dose. 
Odmerek boste morda morali sestaviti z različnimi jakostmi.
During the monotherapy phase, the dose and way you take Temozolomide SUN can vary. 
Med fazo monoterapije se odmerek in način jemanja zdravila Temozolomid SUN lahko spreminjata.
After oral administration of 14C-labelled TMZ, mean faecal excretion of 14C over 7 days post-dose was 0.8 % indicating complete absorption. 
Po peroralnem jemanju TMZ, označenega s 14C, je bila srednja vrednost količine 14C, izločene v blatu 7 dni po odmerku 0,8 %, kar kaže na popolno absorpcijo.
If Temozolomide SUN comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water. 
Če pride zdravilo Temozolomid SUN v stik s kožo ali sluznico, jo takoj temeljito sperite z milom in vodo.
Ask your doctor or pharmacist to write it down (including the marking) - which days are your dosing days. 
Prosite zdravnika ali farmacevta, da vam to napiše (vključno z oznako)
Allergic reactions, including anaphylaxis, angioedema 
alergijske reakcije, vključno z anafilaksijo, angioedem
Pack size: blisters are packed in cartons containing 5 or 20 hard capsules. 
Velikost pakiranja: pretisni omoti so pakirani v kartonskih škatlah s 5 ali 20 trdimi kapsulami.
Following oral administration, approximately 5 % to 10 % of the dose is recovered unchanged in the urine over 24 hours, and the remainder excreted as temozolomide acid, 5-aminoimidazole-4carboxamide (AIC) or unidentified polar metabolites. 
Po peroralni uporabi se v 24 urah s sečem v nespremenjeni obliki izloči približno 5 % do 10 % odmerka, preostanek pa se izloči v obliki temozolomidske kisline, 5-aminoimidazol-4-karboksamida (AIC) ali neopredeljenih polarnih presnovkov.
The hard capsules are available in blister packs containing 5 capsules. 
Trde kapsule so na voljo v pretisnem omotu s 5 kapsulami.
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. 
V natisnjenem navodilu za uporabo zdravila mora biti navedena ime in naslov proizvajalca,
Effective contraceptive precautions must be taken by both male and female patients who are taking Temozolomide SUN (see also “Male fertility” below). 
Bolnice in bolniki, ki jemljejo zdravilo Temozolomid SUN, morajo uporabljati učinkovito kontracepcijsko metodo (glejte tudi spodaj ″Plodnost pri moških)
Patients with tumours that have returned or worsened (malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma) taking Temozolomide SUN only 
Bolniki s tumorji, ki so se ponovili ali poslabšali (maligni gliomi, na primer multiformni glioblastom ali anaplastični astrocitom), ki jemljejo samo zdravilo Temozolomid SUN
During the concomitant phase, your doctor will start Temozolomide SUN at a dose of 75 mg/m2 (usual dose). 
Med fazo sočasnega zdravljenja vam bo zdravnik predpisal zdravilo Temozolomid SUN v odmerku 75 mg/m2 (običajni odmerek).
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Druga zdravila in zdravilo Temozolomid SUN Obvestite zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
The Temozolomide SUN dose may be adjusted, delayed or stopped depending on your blood counts and how you tolerate your medicine during each treatment cycle. 
Odmerjanje zdravila Temozolomid SUN se lahko prilagodi, prestavi ali prekine, odvisno od vaše krvne slike in tega, kako prenašate zdravilo med vsakim ciklom zdravljenja.
Dose during Cycles 2-6 in absence of toxicity 
Odmerek med 2. in 6. ciklom brez toksičnosti
common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000). 
občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki (<1/10.000).
- if you have nausea (feeling sick) and/or vomiting which are very common side effects of Temozolomide SUN (see section 4), your doctor may prescribe you a medicine (an anti-emetic) to help prevent vomiting. 
- vam je slabo in/ali bruhate, kar sta zelo pogosta neželena učinka zdravila Temozolomid SUN (glejte poglavje 4 ),vam bo zdravnik morda predpisal zdravilo, ki preprečuje bruhanje
TMZ dose (mg/m2/day) 
Raven odmerka Odmerek TMZ (mg/m2/dan)
No data are available on the administration of TMZ in patients with severe hepatic impairment (Child's Class C) or with renal impairment. 
Podatki o uporabi TMZ pri bolnikih s hudo jetrno okvaro (razred C po Child-u) ali ledvično okvaro niso na voljo.
Temozolomide SUN contains lactose (a kind of sugar). 
Zdravilo Temozolomid SUN vsebuje laktozo (vrsta sladkorja).
TMZ has minor influence on the ability to drive and use machines due to fatigue and somnolence (see section 4.8). 
4.7 Vpliv na sposobnost vožnje in upravljanja s stroji TMZ ima blag vpliv na sposobnost vožnje in upravljanja s stroji zaradi utrujenosti in zaspanosti (glejte poglavje 4.8).
Your blood will be tested frequently during treatment to monitor the side effects of Temozolomide SUN on your blood cells. 
Med zdravljenjem boste pogosto imeli preiskave krvi za spremljanje neželenih učinkov zdravila Temozolomid SUN na krvne celice.
Temozolomide SUN should not be administered to pregnant women. 
Zdravila Temozolomid SUN se ne sme dajati nosečnicam.
If you have been newly-diagnosed with glioblastoma multiforme you may be receiving Temozolomide SUN for 42 days in combination with radiotherapy. 
Če imate na novo diagnosticiran multiformni glioblastom, boste morda 42 dni dobivali zdravilo Temozolomid SUN v kombinaciji z obsevanjem.
Rare (may affect up to 1 in 1,000 people): cough, infections including pneumonia. 
Redki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): kašelj, okužbe, ki vključujejo pljučnico.
- if the numbers of certain kinds of blood cells, such as your white blood cells or platelets are severely reduced (known as myelosuppression). 
- če imate hudo zmanjšano število nekaterih vrst krvnih celic (znano kot mielosupresija), na primer belih krvnih celic ali krvnih ploščic.
You will take your new dose of Temozolomide SUN once daily for the first 5 days (“dosing days”) of each cycle. 
Nov odmerek zdravila Temozolomid SUN boste prvih pet dni v vsakem ciklu jemali enkrat dnevno (»dnevi odmerjanja«).
Very common (may affect more than 1 in 10 people): loss of appetite, headache, constipation 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov): izguba apetita, glavobol, zaprtje
- if you have liver or kidney problems, your dose of Temozolomide SUN may need to be adjusted. 
- če imate težave z ledvicami ali jetri, bo morda treba vaš odmerek zdravila Temozolomid SUN
Tell your doctor immediately if this occurs. 
Če pride to tega, nemudoma pokličite zdravnika.
What Temozolomide SUN is and what it is used for What you need to know before you take Temozolomide SUN How to take Temozolomide SUN Possible side effects 
Kaj je zdravilo Temozolomid SUN in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Temozolomid SUN Kako jemati zdravilo Temozolomid SUN
- if you are older than 70 years of age, you might be more prone to infection, bruising or bleeding. 
- če dobite vročino ali simptome okužbe, se takoj obrnite na zdravnika - če ste starejši od 70 let, boste lahko bolj nagnjeni k okužbam, podplutbam ali krvavitvam.
There is limited information in patients over 3 years of age who have taken Temozolomide SUN. 
Število podatkov pri bolnikih, starejših od 3 let, ki so jemali zdravilo Temozolomid SUN, je omejeno
In patients 3 years of age or older, TMZ is only to be used in recurrent or progressive malignant glioma. 
Pri bolnikih starih 3 leta ali več, se TMZ uporablja samo za zdravljenje ponavljajočega se ali napredujočega malignega glioma..
Cases of elevations of liver enzymes have been commonly reported. 
Pogosto so poročali o primerih povišanih vrednosti jetrnih encimov.
The Temozolomide SUN dose may be delayed or stopped, depending on your blood counts and how you tolerate your medicine during the concomitant phase. 
Odmerjanje zdravila Temozolomid SUN se lahko prestavi ali prekine, odvisno od vaše krvne slike in tega, kako prenašate zdravilo med fazo sočasnega zdravljenja.